Typical and atypical antipsychotics differentially modulates D2/5-HT2A heterooligomer signaling

被引：0
|
作者：
Gomez-Garcia, Laura [1 ]
Gomez, Sonia [1 ]
Isabel Cadavid, Maria [1 ]
Manuel Brea, Jose [1 ]
Isabel Loza, Maria [1 ]
机构：
[1] Univ Santiago de Compostela, Grp Biofarma, Santiago De Compostela, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2019年 / 125卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P036
引用
收藏
页码：44 / 45
页数：2
相关论文
共 50 条
  • [1] HALLUCINOGENIC LIGAND (±)DOI MODULATE DOPAMINE D2 SIGNALING BY ACTIVATING 5-HT2A PROTOMERS OF A 5-HT2A/D2 HETEROOLIGOMER
    Gomez-Garcia, L.
    Gomez, S.
    Cadavid, M. I.
    Brea, J.
    Loza, M. I.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 70 - 71
  • [2] D2 and 5-HT2 profile of typical and atypical antipsychotics: PET evidence
    Remington, G
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 : 56 - 56
  • [3] Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics
    Lee, T
    Robichaud, AJ
    Boyle, KE
    Lu, YM
    Robertson, DW
    Miller, KJ
    Fitzgerald, LW
    McElroy, JF
    Largent, BL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 767 - 770
  • [4] Atypical antipsychotics, schizophrenia and cortical 5-HT2A receptors
    Collier, DA
    MOLECULAR PSYCHIATRY, 1998, 3 (03) : 211 - 211
  • [5] Butyrophenone analogues in the carbazole series as potential atypical antipsychotics:: synthesis and determination of affinities at D2, 5-HT2A, 5-HT2B and 5-HT2C receptors
    Masaguer, CF
    Raviña, E
    Fontenla, JA
    Brea, J
    Tristán, H
    Loza, MI
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (01) : 83 - 95
  • [6] Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist
    Ohno, Yukihiro
    Okano, Motoki
    Imaki, Junta
    Tatara, Ayaka
    Okumura, Takahiro
    Shimizu, Saki
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 96 (02) : 175 - 180
  • [7] ATYPICAL ANTIPSYCHOTICS: FUNCTIONAL SELECTIVITY OF LIGANDS AT 5-HT2A AND 5-HT2C RECEPTORS
    Clarke, William P.
    Berg, K. A.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 338 - 339
  • [8] Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity:: comparison with typical and atypical conventional antipsychotics
    Bardin, Laurent
    Auclair, Agnes
    Kleven, Mark S.
    Prinssen, Eric P. M.
    Koek, Wouter
    Newman-Tancredi, Adrian
    Depoortre, Ronan
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 (02): : 103 - 118
  • [9] Iloperidone -: Antipsychotic dopamine D2 antagonist 5-HT2A antagonist
    不详
    DRUGS OF THE FUTURE, 2001, 26 (01) : 80 - 80
  • [10] Novel, highly potent and selective serotonin 5-HT2A/dopamine D2 receptor antagonists as potential antipsychotics.
    Lee, TK
    Robichaud, AJ
    Boyle, KE
    Lu, YM
    Chen, WT
    McClung, C
    Deng, W
    Miller, KJ
    McElroy, JF
    Largent, BL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U17 - U17
12345